169 related articles for article (PubMed ID: 25439221)
1. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
Huang B; Li H; Huang L; Luo C; Zhang Y
J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
[TBL] [Abstract][Full Text] [Related]
2. A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma.
Kang H; Heo S; Shin JJ; Ji E; Tak H; Ahn S; Lee KJ; Lee EK; Kim W
J Pathol; 2019 Nov; 249(3):395-408. PubMed ID: 31301177
[TBL] [Abstract][Full Text] [Related]
3. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
Carcinogenesis; 2012 May; 33(5):1113-20. PubMed ID: 22362728
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
Wang J; Li J; Wang X; Zheng C; Ma W
Biochem Biophys Res Commun; 2013 Sep; 439(1):47-53. PubMed ID: 23962428
[TBL] [Abstract][Full Text] [Related]
6. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
[TBL] [Abstract][Full Text] [Related]
9. Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression.
Wang B; Chen H; Zhang C; Yang T; Zhao Q; Yan Y; Zhang Y; Xu F
Cancer Biother Radiopharm; 2018 Jun; 33(5):194-202. PubMed ID: 29916745
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
Li G; Yang F; Xu H; Yue Z; Fang X; Liu J
Biomed Pharmacother; 2015 Jul; 73():154-9. PubMed ID: 26211597
[TBL] [Abstract][Full Text] [Related]
12. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
Xiao F; Zhang W; Chen L; Chen F; Xie H; Xing C; Yu X; Ding S; Chen K; Guo H; Cheng J; Zheng S; Zhou L
J Transl Med; 2013 Aug; 11():195. PubMed ID: 23967867
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
15. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N
FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.
Zeng ZL; Li FJ; Gao F; Sun DS; Yao L
J Surg Oncol; 2013 Feb; 107(2):105-10. PubMed ID: 22767438
[TBL] [Abstract][Full Text] [Related]
18. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
20. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]